WASHINGTON, April 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures.
WAYNE, N.J., Feb. 21 (UPI) -- The phase 3 trial of Nexavar in those with non-small cell lung cancer halted because it didn't increase patient survival, U.S.-based unit of Bayer AG said.
WASHINGTON, Sept. 5 (UPI) -- The U.S. Food and Drug Administration announced approval Wednesday of the first generic versions of the blood pressure and heart medication Coreg.
WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Lamisil (terbinafine hydrochloride) tablets to treat nail fungus infection.
WASHINGTON, April 24 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Ambien (zolpidem tartrate) for the treatment of insomnia.
REYKJAVIK, Iceland, Oct. 18 (UPI) -- Iceland's Actavis Group will pay $810 million to buy Alpharma Inc.'s generic drug business.
